GlassScriptPhysician profile
Nisha Patel
NPI 1326368523
$1,968.71
in general payments reported to CMS, 2019-2025
16 companies · $47.31 in 2025
The $47.31 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $613 · 2022: $551 · 2023: $364 · 2024: $393 · 2025: $47.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $804.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $444.97 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $255.24 | 2021-2023 | Eliquis |
| Boston Scientific Corporation | $198.58 | 2021-2022 | |
| Abbott Laboratories | $180.43 | 2024 | Cardiomems |
| Biotronik INC. | $159.92 | 2021 | |
| Medtronic, INC. | $146.67 | 2023 | Micra |
| Amgen INC. | $142.01 | 2024 | Repatha |
| Impulse Dynamics (USA) INC. | $135.59 | 2023 | Optimizer |
| Shockwave Medical, INC | $121.95 | 2021 | |
| Philips North America LLC | $39.47 | 2022-2023 | |
| Cook Medical LLC | $33.31 | 2021-2025 | Rosen |
| Axonics, INC. | $33.05 | 2024 | Axonics |
| Humacyte Global, INC. | $27.30 | 2025 | Symvess |
| Glaxosmithkline, LLC. | $20.86 | 2024 | Nucala |
| Hydrofera LLC | $16.61 | 2024 | Hydrofera Blue |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $12.75 | 2023 | Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nisha Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.